Literature DB >> 14707441

Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.

M Jung1, S Christgau, M Lukoschek, D Henriksen, W Richter.   

Abstract

OBJECTIVE: Osteoarthritis (OA) is characterized by a progressive degeneration of articular cartilage and loss of joint function. We hypothesized that degradation of articular cartilage results in increased fragmentation of collagen type II. Thus, the concentrations of degradation products of this major cartilage matrix protein may increase in body fluids of patients with OA.
METHODS: Monoclonal antibodies specific for a human collagen type II C-telopeptide (CTx-II) fragment were used in an ELISA for quantification of collagen type II fragments in urine. Clinical assessment of 88 patients with advanced OA of either hip or knee and 48 age-matched controls was performed with the Harris hip score, the Merle d'Aubigné score and a knee score. Joint space narrowing and the Kellgren and Lawrence score were assessed as radiological signs of OA.
RESULTS: The concentration of CTx-II was significantly higher in OA patients compared with controls (527 vs. 190 ng/mmol, p < 0.001) whether the patients were diagnosed with hip OA (n = 51) or knee OA (n = 37). Mean CTx-II levels were higher in hip OA than in knee OA and a slight increase in levels with age was observed in the controls, but not in OA subjects.
CONCLUSION: Elevation of CTx-II in urine of patients with severe OA compared with a control group suggests that collagen type II derived fragments may serve as markers for OA. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707441     DOI: 10.1159/000074419

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  23 in total

1.  Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort.

Authors:  B Mazières; P Garnero; A Guéguen; M Abbal; L Berdah; M Lequesne; M Nguyen; J-P Salles; E Vignon; M Dougados
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

Review 2.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

3.  Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.

Authors:  M F Sowers; C A Karvonen-Gutierrez; M Yosef; M Jannausch; Y Jiang; P Garnero; J Jacobson
Journal:  Osteoarthritis Cartilage       Date:  2009-06-21       Impact factor: 6.576

4.  Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency.

Authors:  Nikolaus A Streich; David Zimmermann; Holger Schmitt; Gerrit Bode
Journal:  Int Orthop       Date:  2011-01-11       Impact factor: 3.075

Review 5.  The evolving role of biomarkers for osteoarthritis.

Authors:  Muneaki Ishijima; Haruka Kaneko; Kazuo Kaneko
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

Review 6.  What is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review.

Authors:  Jeffrey J Nepple; Kayla M Thomason; Tonya W An; Marcie Harris-Hayes; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

7.  Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial.

Authors:  C Kent Kwoh; Frank W Roemer; Michael J Hannon; Carolyn E Moore; John M Jakicic; Ali Guermazi; Stephanie M Green; Rhobert W Evans; Robert Boudreau
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

8.  Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs.

Authors:  Tina T Chowdhury; Ronny M Schulz; Sonpreet S Rai; Christian B Thuemmler; Nico Wuestneck; Augustinus Bader; Gene A Homandberg
Journal:  Arthritis Res Ther       Date:  2010-05-12       Impact factor: 5.156

Review 9.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

10.  Collagen biomarkers for arthritis applications.

Authors:  James D Birmingham; Vladimir Vilim; Virginia B Kraus
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.